Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Aspen Pharma Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (212)
ARTG (8)
Australian public assessment report (AusPar) (2)
Cancellation or suspension (2)
Prescription medicine registration (2)

Date

2024 (6)
2023 (2)
2022 (9)
2020 (11)
2019 (12)
2018 (11)
2017 (92)
2016 (35)
2015 (45)
2014 (2)
2007 (1)

Search

Sponsor content

226 result(s) found, displaying 51 to 60

Aspen Pharma Pty Ltd - Ledermix cement and hardener - Cement, dental, zinc oxide eugenol Cancelled under Section 41GL(d) of the Act

19 June 2018

Cancellation by sponsor

Requested by Aspen Pharma Pty Ltd
AMCAL ANTI-INFLAMMATORY LOZENGES (RASPBERRY FLAVOUR) blister pack Cancelled under Section 30(1)(c) of the Act

18 May 2018

Cancellation by sponsor

Requested by Aspen Pharma Pty Ltd
GUARDIAN PARACETAMOL EXTRA TABLETS capsule shaped tablet blister pack Cancelled under Section 30(1)(c) of the Act

26 March 2018

Cancellation by sponsor

Requested by Aspen Pharma Pty Ltd
PHYSEPTONE methadone hydrochloride 10mg/1mL injection ampoule Cancelled under s30(1)(c)

15 December 2017

Cancellation by sponsor

Requested by Aspen Pharma Pty Ltd
PHYSEPTONE methadone hydrochloride 10mg tablet bottle Cancelled under s30(1)(c)

15 December 2017

Cancellation by sponsor

Requested by Aspen Pharma Pty Ltd
PHYSEPTONE methadone hydrochloride 5mg tablet bottle Cancelled under s30(1)(c)

15 December 2017

Cancellation by sponsor

Requested by Aspen Pharma Pty Ltd
APO-IPRATROPIUM ipratropium bromide anhydrous 250 microgram/mL inhalation ampoule Cancelled under s30(1)(c)

19 October 2017

Cancellation by sponsor

Requested by Aspen Pharma Pty Ltd
APO-IPRATROPIUM ipratropium bromide anhydrous 500 microgram/mL inhalation ampoule Cancelled under s30(1)(c)

19 October 2017

Cancellation by sponsor

Requested by Aspen Pharma Pty Ltd
AusPAR: Voriconazole

10 August 2017

Australian public assessment report (AusPar)

Australian public assessment report for Voriconazole
BUSPAR buspirone hydrochloride 10mg tablet blister pack Cancelled under s30(1)(c)

22 June 2017

Cancellation by sponsor

Requested by Aspen Pharma Pty Ltd

Pages

First page
Previous page
…
Page 2
Page 3
Page 4
Page 5
Current page 6
Page 7
Page 8
Page 9
Page 10
…
Next page
Last page

Is there anything wrong with this page?

Help us improve

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.